Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SQUELCH-C: Eltrombopag in Chronic Hepatitis C With Thrombocytopenia
NCT01821625Phase 3Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Apr 2013
- Primary completion
- Apr 2015
- Countries
- 1
01
Overview
A Phase 3 trial of eltrombopag in Thrombocytopenia, sponsored by UT Southwestern Medical Center. Started Apr 2013; status: terminated.
02
Drugs
eltrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT01821625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01821625.